Arc Research Institute is a 501(c)(3) organization based in Palo Alto, California, registered in 2022, with $122,280,682 in FY2024 revenue. CharityIndex grades it A, and it directs about 77% of spending to programs.
Revenue (FY2024)
$122.3M
▲ 128.1% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$82.8M
Net assets
$100.7M
Employees
155
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Arc Research Institute: 77% to programs · $0 to raise $100 earns a B+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Arc Research Institute: 15 mo reserves · +32% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Arc Research Institute: 5 of 6 checks met earns a A on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Arc Research Institute: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Our mission is to accelerate scientific progress and understand the root causes of complex diseases. this challenge requires researchers across many disciplines to study fundamental biological mechanisms, develop new technologies, and innovate on therapeutic concepts. by doing this, we aim to improve human health by narrowing the gap between discoveries and impact on patients.
Revenue grew from $15.4M (FY2021) to $122.3M (FY2024) across 4 reported years.
Financial snapshot
Operating margin
32.3%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$184.4M
Total liabilities
$83.7M
Net assets
$100.7M
Salaries & benefits
$24.2M
29% of expenses
Board members
3
3 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $122,280,682▲128% | $82,781,856▲28.9% | $100,720,320▲62.8% | $184,388,461▲18.4% | 990 |
| 2023 | $53,611,444▼44.5% | $64,203,698▲95.8% | $61,884,016▼14.6% | $155,698,196▲3.7% | 990 |
| 2022 | $96,576,028▲525% | $32,795,122▲403% | $72,476,270▲734% | $150,115,619▲73.1% | 990 |
| 2021 | $15,446,292 | $6,520,686 | $8,695,364 | $86,734,431 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Alden J Woodrow — $1,141,800 (1.38% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Alden J Woodrow | Chief Operating Officer | 40 | $1,141,800 |
| Patrick D Hsu Phd | Core Investigator/ Co-founder | 40 | $489,195 |
| Julia M Kazaks | General Counsel/ Secretary | 40 | $478,739 |
| Yusuf H Roohani Phd | Group Lead, Machine Learning | 40 | $407,429 |
| Nianzhen Li Phd | Senior Director, Multi-omics Technology Development | 40 | $391,440 |
| Therese A Costello | Head of People | 40 | $352,151 |
| Lynn M Hendrickson | University Relations & Academic Affairs/ Compliance Officer | 40 | $344,044 |
| Lingyin Li Phd | Core Investigator | 40 | $333,725 |
| Nicolle D Seuss | Senior Operations Program Manager | 40 | $290,334 |
| Hani Goodarzi Phd | Core Investigator | 40 | $273,663 |
| Luke A Gilbert Phd | Core Investigator | 40 | $262,408 |
| Silvana M Konermann Phd | Executive Director/ President | 40 | $245,574 |
| Susan T Cull | Senior Finance Manager | 40 | $189,233 |
| Michael K Teng | Head of Finance/ Treasurer (as of 7/01/2024) | 40 | $151,006 |
| Rose E Harris | Finance (until 7/15/24) | 40 | $127,201 |
| Dave Burke | Chief Technology Officer (as of 10/31/2024) | 40 | $65,712 |
| Daniel P Dever Phd | Head of Scientific Operations (until 1/26/24) | 40 | $62,998 |
| Nathaniel Friedman | Director | 1 | $36,000 |
| Reid Hoffman | Director | 1 | $36,000 |
| Susan Li | Director | 1 | $36,000 |
| Contractor | Services | Paid |
|---|---|---|
| Pulse One | Consulting | $1,314,517 |
| Wilmerhale | Legal Services | $371,768 |
| Milltown Partners LP | Marketing | $329,890 |
| Arnold & Porter Kaye Scholer LLP | Legal Services | $267,843 |
| Innovive LLC | Consulting | $218,577 |
13 grants to Arc Research Institute totaling $189.3M, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Dechomai Foundation Inc | Unrestricted | 2024 | $70,094,690 |
| Alzheimers Disease and Related Disorders Association Inc | Program support | 2024 | $200,000 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2023 | $12,000,000 |
| National Philanthropic Tr | Public, societal benefit | 2023 | $7,000,000 |
| Donor Advised Charitable Giving | Public, societal benefit | 2023 | $2,000,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $1,901,000 |
| Dechomai Foundation Inc | Unrestricted | 2022 | $65,000,040 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2022 | $12,000,000 |
| National Philanthropic Tr | Health | 2022 | $2,000,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2022 | $100,000 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2021 | $10,000,000 |
| New Venture Fund | Health | 2021 | $4,955,000 |
| Donor Advised Charitable Giving | Public, societal benefit | 2021 | $2,000,000 |
7 grants totaling $11.3M in FY2024. All grants made by Arc Research Institute →
| Recipient | Purpose | Amount |
|---|---|---|
| University of San Francisco | Goldberg-benioff endowed professorship in prostate cancer translational biology | $4,000,000 |
| The Board of Trustees of the Leland Stanford Junior University | University fellowships | $3,794,924 |
| The Board of Trustees of the Leland Stanford Junior University | Innovation investigator | $1,330,409 |
| University of California San Francisco | Innovation investigator | $1,265,000 |
| Regents of the University of California At Berkeley | Innovation investigator | $605,000 |
| Regents of the University of California At Berkeley | Funds to cover the cost of a ucb instructor not teaching classes | $157,500 |
| University of California San Francisco | Ignite awards | $110,000 |
Explore more
Data for Arc Research Institute (EIN 87-1920284) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.